loading

Akari Therapeutics Plc Adr Azioni (AKTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
3.525
- - - -
Operating Income/Loss
33.21%
-3.525
-5.278 -2.927 -7.449 -5.989
Nonoperating Income/Loss
111.95%
-0.18
1.506 0.032 -0.109 0.423
Income/Loss From Continuing Operations Before Tax
1.78%
-3.705
-3.772 -2.895 -7.558 -5.566
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
1.78%
-3.705
-3.772 -2.895 -7.558 -5.566
Net Income/Loss
1.78%
-3.705
-3.772 -2.895 -7.558 -5.566
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
997.01%
54,588.28
4,976.08 24,386.01 18,836.48 13,453.15
Diluted Average Shares
997.01%
54,588.28
4,976.08 24,386.01 18,836.48 13,453.15
Basic Earnings Per Share
-
- - - -
Diluted Earnings Per Share
-
- - - -
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
Capitalizzazione:     |  Volume (24 ore):